Roche reports boom in cancer drug sales

Roche, the world’s largest cancer drug manufacturer, has reported a 6% rise in sales.

Sales of major brands including Rituxan, Avastin, and Herceptin have exceeded expected demand in Q1 of 2010.

Sales went up by 6 percent to $11.61 billion or 12.2 billion Swiss Francs. For full article then please refer to the news pages of Kirkham Young. This is further evidence of the demand for medical sales professionals

Leave a Reply